Purdue Pharma’s $6 Billion Opioid Settlement in Limbo as U.S. Supreme Court Agrees to Review Bankruptcy Plan
- August 11, 2023
The U.S. Supreme Court agreed August 9 to review the Department of Justice’s challenge to Purdue Pharma L.P.’s bankruptcy plan, temporarily blocking a $6 billion opioid settlement that the government said would improperly shield the company’s owners from future opioid-related lawsuits.
ARTICLE TAGS
You must be logged in to access this content.